GHP NewsLatest Science AMETA nanobody platform breakthrough tackles viral mutations Scientists at the Icahn School of Medicine at Mount Sinai have developed a novel antibody platform called the Adaptive Multi-Epitope Targeting and Avidity-Enhanced (AMETA) Nanobody Platform, designed to counteract viral... 25 October, 20242 min read